How do psychedelics work?
Carhart-Harris, R. L. | Current opinion in psychiatry | 1 January 2019
Role of serotonin transporter and receptor gene variations in the acute effects of MDMA in healthy subjects
Vizeli, P., Meyer zu Schwabedissen, H. E., & Liechti, M. E. | ACS chemical neuroscience | 27 December 2018
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018
Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom
Torrens-Spence, M. P., Liu, C. T., Pluskal, T., Chung, Y. K., & Weng, J. K. | ACS chemical biology | 28 November 2018
Self-Experiments with Psychoactive Substances: A Historical Perspective
Passie, T., & Brandt, S. D. | Handbook of Experimental Pharmacology | 27 November 2018
Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis
Müller, F., Brändle, R., Liechti, M. E., & Borgwardt, S. | Neuroscience & Biobehavioral Reviews | 12 November 2018
What Psilocybin Taught Me About Dying
Back, A. L. | Journal of palliative medicine | 9 November 2018
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., & Vollenweider, F. X. | eLife | 25 October 2018
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
Kivell, B., Paton, K., Kumar, N., Morani, A., Culverhouse, A., Shepherd, A., ... & Prisinzano, T. | Molecules | 11 October 2018
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug
Jalal, B. | Psychopharmacology | 5 October 2018
Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
Müller, F., Liechti, M. E., Lang, U. E., Borgwardt, S., Wilson, M. R., Webb, A., ... & Lutz, K. | Progress in brain research | 28 September 2018
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
Deco, G., Cruzat, J., Cabral, J., Knudsen, G. M., Carhart-Harris, R. L., Whybrow, P. C., & Kringelbach, M. L. | Current biology | 27 September 2018
Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
Olson, D. E. | Journal of experimental neuroscience | 19 September 2018
Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model
Peto, K., Nemeth, N., Mester, A., Magyar, Z., Ghanem, S., Somogyi, V., ... & Nemes, B. | Clinical hemorheology and microcirculation | 14 September 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. | Psychopharmacology | 8 September 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., ... & Emerson, A. | Psychopharmacology | 8 September 2018
Serotonin, psychedelics and psychiatry
Carhart‐Harris, R. L. | World Psychiatry | 7 September 2018
DMT Models the Near-Death Experience
Timmermann, C., Roseman, L., Williams, L., Erritzoe, D., Martial, C., Cassol, H., ... & Carhart-Harris, R. | Frontiers in psychology | 15 August 2018
Psychedelics and psychotherapy in Canada: Humphry Osmond and Aldous Huxley.
Dyck, E., & Farrell, P. | History of psychology | August 2018
Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics
Mason, N. L., & Kuypers, K. P. | Journal of Psychedelic Studies | 25 June 2018
Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects
Vizeli, P., & Liechti, M. E. | PloS one | 18 June 2018
Dark Classics in Chemical Neuroscience: Mescaline
Cassels, B., & Sáez-Briones, P. | ACS chemical neuroscience | 8 June 2018
Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network.
Mueller, F., Musso, F., London, M., de Boer, P., Zacharias, N., & Winterer, G. | NeuroImage: Clinical | 1 June 2018
Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
Gabay, A. S., Carhart-Harris, R. L., Mazibuko, N., Kempton, M. J., Morrison, P. D., Nutt, D. J., & Mehta, M. A. | Scientific reports | 29 May 2018
Psychedelic use and intimate partner violence
Thiessen, M. S., Walsh, Z., Bird, B. M., & Lafrance, A. | Journal of psychopharmacology | 29 May 2018